scholarly journals Using the CA Opioid Overdose Surveillance Dashboard to track opioid overdose deaths

Author(s):  
Jaynia Anderson ◽  
Natalie Demeter ◽  
Mar-y-sol Pasquires ◽  
Stephen Wirtz

ObjectiveDemonstrate the use of timely, actionable data from a data visualization tool, the California Opioid Overdose Surveillance Dashboard, which integrates statewide, geographic- and demographic-specific data, by describing the changes in opioid overdose deaths in California.IntroductionCalifornia continues to face a serious public health crisis with the opioid epidemic having substantial health and economic impacts. The epidemic is dynamic and rapidly changing, involving both prescription opioids influenced by prescribing and dispensing patterns as well as illicit opioids influenced by the availability of heroin and recently, the increased availability of fentanyl. The complexity of the issue necessitates data-informed actions through multi-sector, strategic collaboration at both the state and local levels to address the problem comprehensively. With nearly 2,000 opioid overdose deaths per year and wide variation of overdose rates across counties and demographic groups, there is a need for integrated, timely, actionable data for use by state policy makers, local opioid safety coalitions, media, community stakeholders, and the public to monitor and combat this dynamic epidemic at the state and local level. Using fatality data from the California Opioid Overdose Surveillance Dashboard1, the opioid overdose epidemic is described along with the differential geographic and demographic impacts.MethodsAs part of California Department of Public Health’s Prevention for States grant funded by the Centers for Disease Control and Prevention, the California Opioid Overdose Surveillance Dashboard was developed as a data tool to provide enhanced visualization and integration of non-fatal and fatal opioid-involved overdose data and opioid prescription data. The dashboard was built on an open source RStudio server using Shiny, an R package that provides a framework for building web applications. Data incorporated on the dashboard include emergency department visits, hospitalizations, fatalities, and prescriptions related to opioid overdoses among California residents, presented in raw counts, crude rates, and age-adjusted rates at the state, county, and zip code levels, as well as by sex, age, and race/ethnicity. Overdose deaths are identified using ICD-10 (International Classification of Diseases, 10th Revision) codes X40-X44, X60-X64, X85, Y10-Y14, and T40.0-T40.6, recorded in the underlying cause of death and multiple cause of death fields on death certificates. Fentanyl overdose deaths are identified using a text search on contributing cause of death fields on death certificates. Using data from the California Opioid Overdose Surveillance Dashboard, we present one perspective of the epidemic by using 2017 death data to describe the changing trend and geographic and demographic variation of prescription drug, heroin, and fentanyl overdose deaths.ResultsOverall trends from 2011-2017 show that deaths due to opioid overdoses have increased. Prescription drug overdose death rates have slightly decreased by 6% from 3.93/100,000 in 2011 to 3.7/100,000 in 2017. Heroin overdose death rates have increased by 89% from 0.90/100,000 in 2011 to 1.70/100,000 in 2017. Fentanyl overdose death rates have increased by 320% from 0.25/100,000 in 2011 to 1.05/100,000 in 2017. The highest rates of prescription opioid overdose deaths are primarily concentrated in northern rural counties, while the highest rates of heroin and fentanyl overdose deaths are more dispersed throughout the state with many coastal counties showing higher rates of overdose deaths (Figure 1). Prescription opioid overdose deaths are concentrated among older ages showing highest rates among 55 to 59 year olds (8.27/100,000). In contrast, heroin and fentanyl overdose death rates are concentrated among younger ages with the highest rates seen among 25 to 29 year olds, 4.54/100,000 and 2.78/100,000, respectively (Figure 2). Males died from prescription opioid, heroin, and fentanyl overdoses at significantly higher rates than females. Prescription opioid and fentanyl overdose death rates (11.5/100,000 and 4.80/100,000, respectively) are significantly higher among Native Americans compared to other races/ethnicities (Table 1). Non-Hispanic whites had significantly higher prescription opioid and heroin overdose death rates (6.90/100,000 and 2.96/100,000, respectively) compared to non-Hispanic black, Hispanic, and Asian residents of California.ConclusionsFatality data from 2017 show the characteristics of the opioid overdose epidemic in California are changing. While still high, overdose deaths from prescription opioids, seen primarily in older age groups and northern rural California, are slightly declining. Concurrently, we are seeing sharp rises in heroin and fentanyl overdose death rates among younger adults throughout the state. Regardless of any change in trend, there remain clear disparities in overdose death rates by race/ethnicity; with Native Americans having the highest rates for both prescription and illicit opioids, and non-Hispanic whites have higher rates of prescription opioid and heroin overdose deaths.Given the varying demographic and geographic impacts based on the type of opioid, as demonstrated with the use of death data, there needs to be targeted data-informed interventions to address and prevent prescription and illicit opioid overdoses. Death data is just one perspective on the epidemic, other data sources (emergency department visits, hospitalizations, and prescriptions) are needed complete the picture to truly provide a robust data-informed approach. The California Opioid Overdose Surveillance dashboard integrates these multiple data sources and serves as a valuable tool in providing specific and timely data to inform approaches and interventions at the state and local level in continuing to fight California’s opioid overdose epidemic. The enhanced visualization, geographic- and demographic-specific data, and increasingly timely data allow for state and local policy makers, local opioid safety coalitions, and community stakeholders to track the dynamics and impact of the epidemic and to identify those who are most vulnerable and differentially impacted.References1 California Opioid Overdose Surveillance Dashboard https://discovery.dev.cdph.ca.gov/CDIC/ODdash/ 

2019 ◽  
Vol 34 (s1) ◽  
pp. s53-s53
Author(s):  
Sasha Rihter ◽  
Nathan Menke

Introduction:The opioid epidemic is overwhelming communities across the United States. West Virginia (WV) has been devastated, heralding a 86% increase in deaths from 2012-2016, and over 1,000 deaths last year as per WV Health Statistics Center. Treatment centers and providers have emerged throughout the state to provide medication-assisted treatment (MAT). The impact of these clinics on the opioid abusing population is not yet fully understood.Aim:Utilizing Geographic Information System (GIS), a comparison of MAT provider locations versus regions of historical overdoses can indicate areas of deficiency. If no providers emerge in underserved counties, overdose deaths in those areas will continue to rise.Methods:Maps were created using current DEA-X licenses in WV registered through Substance Abuse and Mental Health Services Administration (SAHMSA). Overdose death rates were taken from WV Public Health Records from 2010-2017. Two maps and corresponding data were compared for overlap or lack thereof.Results:Of the 338 locations of DEA-X licenses registered, 17.5% are in Cabell County, which led the state in overdose deaths in 2017. Only 2.5% of the total providers are currently in Wayne County, which had the second highest overdose death rate. Berkeley County, which was 3rd highest, has a mere 6.5% of total providers. Comparatively, Kanawah County, home to the state’s capital, has over twice this number of providers despite consistently having at or below the state average of overdose rates. Resources are pulled towards population-dense areas or university centers, where the epidemic is present but misses counties with higher overdose rates.Discussion:Results show a lack of MAT providers in many of WV’s devastated counties. Treatment centers exist throughout the state but are concentrated in regions with large cities or academic centers. This distribution limits accessibility to a marginalized patient population, making improvements unlikely in WV’s future opioid-overdose death rates.


2021 ◽  
Author(s):  
Gian-Gabriel P. Garcia ◽  
Erin Stringfellow ◽  
Catherine DiGennaro ◽  
Nicole Poellinger ◽  
Jaden Wood ◽  
...  

Background: Since COVID-19 erupted in the United States, little is known about how state-level opioid overdose trends and decedent characteristics have varied throughout the country. Objective: Investigate changes in annual overdose death rates, substances involved, and decedent demographics in opioid overdose deaths across nine states; assess whether 2019-2020 trends were emerging (i.e., change from 2019-2020 was non-existent from 2018-2019) or continuing (i.e., change from 2019-2020 existed from 2018-2019). Design: Cross-sectional study using vital statistics data to conduct a retrospective analysis comparing 2020 to 2019 and 2019 to 2018 across nine states. Setting: Alaska, Colorado, Connecticut, Indiana, Massachusetts, North Carolina, Rhode Island, Utah, and Wyoming. Participants: Opioid-related overdose deaths in 2018, 2019, and 2020. Measurements: Annual overdose death rate, proportion of overdose deaths involving specific substances, and decedent demographics (age, sex, race, and ethnicity). Results: We find emerging increases in annual opioid-related overdose death rates in Alaska (55.3% [P=0.020]), Colorado (80.2% [P<0.001]), Indiana (40.1% [P=0.038]), North Carolina (30.5% [P<0.001]), and Rhode Island (29.6% [P=0.011]). Decreased heroin-involved overdose deaths were emerging in Alaska (-49.5% [P=0.001]) and Indiana (-58.8% [P<0.001]), and continuing in Colorado (-33.3% [P<0.001]), Connecticut (-48.2% [P<0.001]), Massachusetts (39.9% [P<0.001]), and North Carolina (-34.8% [P<0.001]). Increases in synthetic opioid presence were emerging in Alaska (136.5% [P=0.019]) and Indiana (27.6% [P<0.001]), and continuing in Colorado (44.4% [P<0.001]), Connecticut (3.6% [P<0.05]), and North Carolina (14.6% [P<0.001]). We find emerging increases in the proportion of male decedents in Colorado (15.2% [P=0.008]) and Indiana (12.0% [P=0.013]). Limitations: Delays from state-specific death certification processes resulted in varying analysis periods across states. Conclusion: These findings highlight emerging changes in opioid overdose dynamics across different states, which can inform state-specific public health interventions.


2021 ◽  
pp. e1-e4
Author(s):  
Marc R. Larochelle ◽  
Svetla Slavova ◽  
Elisabeth D. Root ◽  
Daniel J. Feaster ◽  
Patrick J. Ward ◽  
...  

Objectives. To examine trends in opioid overdose deaths by race/ethnicity from 2018 to 2019 across 67 HEALing Communities Study (HCS) communities in Kentucky, New York, Massachusetts, and Ohio. Methods. We used state death certificate records to calculate opioid overdose death rates per 100 000 adult residents of the 67 HCS communities for 2018 and 2019. We used Poisson regression to calculate the ratio of 2019 to 2018 rates. We compared changes by race/ethnicity by calculating a ratio of rate ratios (RRR) for each racial/ethnic group compared with non-Hispanic White individuals. Results. Opioid overdose death rates were 38.3 and 39.5 per 100 000 for 2018 and 2019, respectively, without a significant change from 2018 to 2019 (rate ratio = 1.03; 95% confidence interval [CI] = 0.98, 1.08). We estimated a 40% increase in opioid overdose death rate for non-Hispanic Black individuals (RRR = 1.40; 95% CI = 1.22, 1.62) relative to non-Hispanic White individuals but no change among other race/ethnicities. Conclusions. Overall opioid overdose death rates have leveled off but have increased among non-Hispanic Black individuals. Public Health Implications. An antiracist public health approach is needed to address the crisis of opioid-related harms. (Am J Public Health. Published online ahead of print September 9, 2021:e1–e4. https://doi.org/10.2105/AJPH.2021.306431 )


2020 ◽  
Vol 48 (2) ◽  
pp. 249-258 ◽  
Author(s):  
Brandi C. Fink ◽  
Olivier Uyttebrouck ◽  
Richard S. Larson

Overdose deaths involving prescription opioids killed more than 17,000 Americans in 2017, marking a five-fold increase since 1999. High prescribing rates of opioid analgesics have been a substantial contributor to prescription opioid misuse, dependence, overdose and heroin use. There was recognition approximately ten years ago that opioid prescribing patterns were contributing to this startling increase in negative opioid-related outcomes, and federal actions, including Medicare reimbursement reform and regulatory actions, were initiated to restrict opioid prescribing. The current manuscript is a description of those actions, the effect of those actions on opioid prescribing and related patient outcomes. We also describe our proposal of methods of expanding these efforts as an important piece to further reduce opioid-related misuse, dependence, and overdose death.


2020 ◽  
Vol 44 (7) ◽  
pp. 672-678
Author(s):  
Rachel Bonk ◽  
Ross J Miller ◽  
Joshua Lanter ◽  
Cheryl Niblo ◽  
Jesse Kemp ◽  
...  

Abstract To evaluate trends related to accidental overdose deaths in Oklahoma, with a focus on opioids and methamphetamine. All accidental drug overdose deaths in the state of Oklahoma from 2002 to 2017 were reviewed. Opioids were grouped into the following categories: all opioids, prescription opioids, synthetic opioids and heroin. Age-adjusted death rates for methamphetamine and each opioid category were calculated and analyzed. Accidental overdoses accounted for 9,936 deaths during the study period. Of these, opioids were seen in 62.9%, with prescription opioids comprising 53.8%, synthetic opioids 10.3% and heroin 2.8%. Synthetic opioids, despite a recent upward nationwide trend, showed a slight overall decrease (−6.8%) from 2009 to 2017. In contrast, methamphetamine showed a 402.2% increase from 2009 to 2017 and an overall increase of 1,526.7%. Methamphetamine was involved in the most overdoses (1,963), followed by oxycodone (1,724). Opioid-related deaths were most common among white individuals (90.3%) and showed a slight male predilection (56.9%). With the intent of assessing the opioid epidemic as it relates to accidental overdoses in Oklahoma, this study suggests that opioid-related overdoses have slowed in recent years amidst a sharp increase in methamphetamine deaths.


Sign in / Sign up

Export Citation Format

Share Document